WMT

116.69

+1.06%↑

142.76

+1.54%↑

70.51

+2.01%↑

153.5

+1.79%↑

PEP

150.62

+1.08%↑

WMT

116.69

+1.06%↑

142.76

+1.54%↑

70.51

+2.01%↑

153.5

+1.79%↑

PEP

150.62

+1.08%↑

WMT

116.69

+1.06%↑

142.76

+1.54%↑

70.51

+2.01%↑

153.5

+1.79%↑

PEP

150.62

+1.08%↑

WMT

116.69

+1.06%↑

142.76

+1.54%↑

70.51

+2.01%↑

153.5

+1.79%↑

PEP

150.62

+1.08%↑

WMT

116.69

+1.06%↑

142.76

+1.54%↑

70.51

+2.01%↑

153.5

+1.79%↑

PEP

150.62

+1.08%↑

Strona główna・Stock List・Lifecore Biomedical Inc

Lifecore Biomedical Inc

Closed

SectorConsumer defensive

7.8 0.13

Buy Sell

Overview

Share price change

24h

Current

Min

7.62

Max

7.89

Key metrics
By Trading Economics
Income	-7.9M -10M
Sales	-5.3M 31M
Profit margin	-32.116
Employees	406

Dividends
By Dow Jones
Next Earnings	2 sty 2026

Market Stats
By TradingEconomics
Market Cap	7.5M 249M
Previous open	7.67
Previous close	7.8

News Sentiment

By Acuity

20%

80%

16 / 148 Ranking in Consumer defensive

Lifecore Biomedical Inc Chart

Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.

Related News

12 gru 2025, 16:42 UTC

Acquisitions, Mergers, Takeovers

FTC Sues to Block Henkel's $725 Million Deal for Liquid Nails From PE Firm -- 2nd Update

12 gru 2025, 23:49 UTC

Acquisitions, Mergers, Takeovers

Intel in Talks to Acquire SambaNova in Deal Valued at $1.6B, Bloomberg Reports, Citing Sources

12 gru 2025, 22:52 UTC

Market Talk

Nike Expected to Show Further Momentum in 2Q Results -- Market Talk

12 gru 2025, 22:32 UTC

Earnings

These Stocks Moved the Most Today: Broadcom, Oracle, Fermi, Tilray, Lululemon, Costco, Netskope, and More -- Barrons.com

12 gru 2025, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

12 gru 2025, 20:45 UTC

Earnings

The Best Dividend ETF for Right Now -- and 2026 -- Barrons.com

12 gru 2025, 20:41 UTC

Market Talk

Oil Ends Week Lower As Market Frets About Oversupply -- Market Talk

12 gru 2025, 20:20 UTC

Market Talk

U.S. Natural Gas Futures Post Hefty Weekly Loss -- Market Talk

12 gru 2025, 19:23 UTC

Earnings

Charles Schwab Is Opening New Accounts and Hauling in New Assets Amid Buoyant Stock Market -- Barrons.com

12 gru 2025, 18:35 UTC

Acquisitions, Mergers, Takeovers

PNC Financial Expects to Close FirstBank Deal On or About Jan. 5, Subject to Satisfaction of Customary Closing Conditions

12 gru 2025, 18:33 UTC

Acquisitions, Mergers, Takeovers

PNC Receives Regulatory Approvals For Acquisition Of FirstBank >PNC

12 gru 2025, 18:31 UTC

Market Talk

U.S. Oil Rig Count Edges Up by 1 to 414 -- Market Talk

12 gru 2025, 17:49 UTC

Earnings

Tariffs Mean Costco Has Fewer Product Types This Holiday. But It Has Plenty of Pies. -- WSJ

12 gru 2025, 17:34 UTC

Acquisitions, Mergers, Takeovers

Orange: Closing Subject to Customary Regulatory Approvals, Other Closing Conditions

12 gru 2025, 17:33 UTC

Acquisitions, Mergers, Takeovers

Orange: Closing of the Transaction Is Expected in the First Half of 2026

12 gru 2025, 17:33 UTC

Acquisitions, Mergers, Takeovers

Orange: Agreement Confirms the Non-Binding Agreement That Was Previously Announced Oct. 31

12 gru 2025, 17:32 UTC

Acquisitions, Mergers, Takeovers

Orange: MasOrange Is Spain's Leading Operator in Terms of Customer Base

12 gru 2025, 17:31 UTC

Acquisitions, Mergers, Takeovers

Orange to Buy the Stake for EU4.25B in Cash

12 gru 2025, 17:24 UTC

Market Talk

Argentina Predicts Record Wheat Crop -- Market Talk

12 gru 2025, 17:20 UTC

Market Talk

Earnings

Tech, Media & Telecom Roundup: Market Talk

12 gru 2025, 17:20 UTC

Market Talk

Basic Materials Roundup: Market Talk

12 gru 2025, 17:18 UTC

Market Talk

Earnings

Broadcom, Oracle Investor Reactions Show High Bar for AI Cos. -- Market Talk

12 gru 2025, 17:09 UTC

Market Talk

Broadcom Investors Were Primed to Sell Shares -- Market Talk

12 gru 2025, 17:09 UTC

Market Talk

Global Equities Roundup: Market Talk

12 gru 2025, 16:47 UTC

Market Talk

Broadcom's Margins Expected to Narrow Due to AI Revenue -- Market Talk

12 gru 2025, 16:39 UTC

Market Talk

Supply Limits, Geopolitical Risk to Support Crude in 2026 -- Market Talk

12 gru 2025, 16:27 UTC

Acquisitions, Mergers, Takeovers

FTC Sues to Block Henkel's $725M Deal for Liquid Nails From PE Firm -- 2nd Update

12 gru 2025, 16:15 UTC

Earnings

At Costco, Lots of Pie but No Special Dividend. Why the Street Didn't Like the Earnings. -- Barrons.com

12 gru 2025, 15:35 UTC

Earnings

These Stocks Are Moving the Most Today: Broadcom, Oracle, Fermi, Tilray, Lululemon, Costco, Netskope, and More -- Barrons.com

12 gru 2025, 14:46 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

Peer Comparison

Price change

Lifecore Biomedical Inc Forecast

Rating Consensus

By TipRanks

Buy

4 ratings

Buy

Hold

Sell

Based on 4 analysts giving stock ratings to Lifecore Biomedical Inc - Dist in the past 3 months.

Sentiment

By Acuity

16 / 148 Ranking in Consumer defensive

Financials

Selling and administration expenses

Operating expenses

Pre-tax profit

Sales

Cost of sales

Gross profit on sales

Interest expense on debt

EBITDA

Operating profit

About Lifecore Biomedical Inc

Lifecore Biomedical, Inc., together with its subsidiaries, operates as an integrated contract development and manufacturing organization in the United States. The company engages in the manufacturing of injectable grade sodium hyaluronate (HA) in bulk form, as well as formulated and filled syringes and vials for injectable products used in treating a range of medical conditions and procedures. It also provides services, such as technology development, material component changes, analytical method development, formulation development, pilot studies, stability studies, process validation, and production of materials for clinical studies to its partners for HA-based and non-HA based aseptically formulated and filled products. The company was formerly known as Landec Corporation and changed its name to Lifecore Biomedical, Inc. in November 2022. Lifecore Biomedical, Inc. was founded in 1965 and is headquartered in Chaska, Minnesota.